Evidence map›Paper›PMID 20566741›Full record

ArticleThe American journal of pathology2010

Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis.

Laurie T Krug, Edilson Torres-González, Qianhong Qin, Dan Sorescu, Mauricio Rojas, Arlene Stecenko, Samuel H Speck, Ana L Mora

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Virus infection induced pulmonary fibrosis.Journal of translational medicine · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis.American journal of respiratory cell and molecular biology · 2012
    Article
  19. Article
  20. Nuclear factor-κB: a key regulator in health and disease of lungs.Archivum immunologiae et therapiae experimentalis · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 3 countries.

Laurie T KrugDepartment of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.
Edilson Torres-González
Qianhong Qin
Dan Sorescu
Mauricio Rojas
Arlene Stecenko
Samuel H Speck
Ana L Mora
Emory University · US

Funding

Role of B Cells in Murine Gammaherpesvirus-68 LatencyR01CA095318 · NCI · EMORY UNIVERSITY · PI SCHARER, CHRISTOPHER D · 2003 to 2019
$4.9M
Nox4 and Cardiac FibrosisR01HL090851 · NHLBI · EMORY UNIVERSITY · PI SORESCU, DAN · 2008 to 2012
$2.2M
Immunobiology of Lung FibrosisK01HL073154 · NHLBI · EMORY UNIVERSITY · PI MORA, ANA LUCIA · 2003 to 2007
$641k
The role of NF-kappa B in gammaherpersvirus 68 latencyF32AI066818 · NIAID · EMORY UNIVERSITY · PI KRUG, LAURIE T · 2005 to 2007
$161k
NCI NIH HHS R01 CA095318NCI NIH HHS R01 CA95318NHLBI NIH HHS K01 HL073154NHLBI NIH HHS R01 HL090851NHLBI NIH HHS R01HL090851-02S1NIAID NIH HHS F32 AI066818
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disorder of unknown etiology. Several studies have demonstrated an association between pulmonary infection with a herpesvirus and IPF. Based on those observations, we have developed a mouse model in which interferon (IFN)gammaR(-/-) mice infected intranasally with murine gammaherpesvirus 68 (MHV68) develop lung fibrosis. We hypothesize that viral load was a critical factor for the development of fibrosis. Because nuclear factor (NF)-kappaB signaling is required to efficiently establish gammaherpesvirus, latency we infected IFNgammaR(-/-) mice with a MHV68 virus that expresses a mutant dominant inhibitor of the NF-kappaB signaling pathway, called IkappaBalphaM. Striking differences were observed at the onset of the chronic infection, which correlated with a decreased virus load in mice infected with MHV68-IkappaBalphaM compared with mice infected with control MHV68 (MHV68-MR). IFNgammaR(-/-) mice infected with MHV68-IkappaBalphaM lacked vasculitis and fibrosis 15 to 120 days post infection. Inhibition of NF-kappaB in MHV68-infected cells of the lungs diminished the expression of the fibrocyte recruiting chemokines monocyte chemoattractant protein 1 (MCP-1) and CXCL12, ameliorated macrophage expression of markers of alternative activation, and failed to increase expression of the integrin alphavbeta6, which is implicated in the activation of the profibrotic factor TGF-beta. Thus, the inhibition of NF-kappaB signaling in the infected lung cells of IFNgammaR(-/-) mice reduces virus persistence and ameliorates profibrotic events. Host determinants of latency might therefore represent new therapeutic targets for gammaherpesvirus-associated pulmonary fibrosis.

Indexed as

LungAnimalsCells, CulturedGammaherpesvirinaeHerpesviridae InfectionsInflammationInterferon gamma ReceptorMiceMice, Inbred C57BLMice, KnockoutNF-kappa BPulmonary FibrosisReceptors, InterferonSignal TransductionTransforming Growth Factor beta1Viral LoadInterferon gamma ReceptorNF-kappa BReceptors, InterferonTransforming Growth Factor beta1

Identifiers

PMID20566741
PMCPMC2913377
OpenAlexW1963967314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.